Nobilis Therapeutics
3042 NW Monte Vista Terrace
Portland
Oregon
97210
United States
Tel: 971-229-1679
Website: http://www.nobilistx.com/
Email: info@nobilistx.com
About Nobilis Therapeutics
Nobilis Therapeutics is a Delaware C-corporation that is focused on therapeutic uses of inert gas mixtures and development of portable devices for their self-administration.Founded by a drug developer, a scientist and a pioneer of medical gas research, the Company has been able to capture the field and in a very short time has accomplished a tremendous amount. Nobilis Therapeutics has entered into an exclusive licensing agreement with Harvard University on the use of NBTX-001 to treat PTSD, filed 10 patents, and is well positioned to initiate 2 clinical trials in the coming months.
YEAR FOUNDED:
2015
LEADERSHIP:
President & CEO: Dr. Vlad Bogin, MD, FACP.
PRODUCTS
Please click here for Nobilis Therapeutics' products.
3 articles about Nobilis Therapeutics
-
Nobilis Therapeutics to Present at CapCon 2020 Venture Conference
10/30/2020
Nobilis Therapeutics, a late stage biotechnology company that is developing a drug-device combination for treatment of psychiatric disorders will present at the virtual CapCon 2020 Venture Conference, Nov 16-17. The most rapidly growing psychiatric diagnosis in the United States, PTSD, is a devastating psychiatric condition associated with tremendous emotional and financial costs to the health care system. According to National Center for PTS
-
Nobilis Health Reports Fourth Quarter and Full Year 2017 Financial Results
3/8/2018
Full year total revenue of $299.7 million, a 4.9% increase over prior year
-
Nobilis Receives A Notice Of Allowance For A Patent Covering Treatment Of Psychiatric Disorders With Noble Gases
6/13/2017